VBL Therapeutics to Present Data on its Novel VB-600 Platform at Keystone Conference on February 26

NEXT STORY
Letter to Shareholders from Curt Fairbrother, CEO The Medtainer™
PREV STORY
Aptose to Present at the 8th Annual SVB Leerink Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization

author_avatar
NASDAQ Market News

Gradalis Announces Publication of Phase 2b VITAL trial of Vigil® demonstrating RFS and OS advantage in women with first-line platinum-responsive BRCA1 and BRCA2 wild-type advanced ovarian cancer in The Lancet Oncology

author_avatar
NASDAQ Market News

ChemoCentryx Reports Third Quarter 2021 Financial Results and Recent Highlights

author_avatar
NASDAQ Market News